BioWorld MedTech

May 20, 2011

DES beauty contest pits device and patient criteria

PARIS – Participants can be quickly buried under an avalanche of new clinical trial results each year at EuroPCR, Europe's largest congress for interventional cardiologists. (Medical Device Daily) Read More

Is innovation going elsewhere? Well, yes, and here's why

Deals roundup: Thermo Fisher on the hunt to buy Phadia for $3.5 billion

Washington roundup: High court: FOIA docs not eligible for qui tam lawsuits

Report from Europe: Tryton gains CE mark for side branch stent

People in the News

MDD's food for med-tech thought

Agreements/contracts: Mitomics joins QDx to market QPredict

Clarification

Financings roundup: Metabolix commences public stock offering

Medtronic unveils data from CoreValve trials

Patents roundup: Zynx broadens scope of patent coverage in U.S.

HIT roundup: Texas hospital pioneers online effort to get patient feedback

Product Briefs

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for May 2, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for May 2, 2025.

CMS vows to put more emphasis on MA plans’ prior authorization

BioWorld MedTech

Physicians aren’t the only ones who see prior authorization (PA) practices as a significant problem, but John Brooks, deputy administrator at CMS, told a med tech...

US flag, stock market chart, White House

100 days of uncertainty

BioWorld

The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...

Filling the NIH funding gap to protect biopharma research

BioWorld

The Trump administration’s broad slash to university research budgets raises pertinent questions over impacts to the biopharma ecosystem, specifically how a...